Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer

Fig. 3

Kaplan–Meier survival curves according to the incorporation of ESCC-PS and PD-L1 in validation cohort. A Kaplan–Meier survival curves of PFS (2.6 vs 4.5 vs 12.9 months, P < 0.001) according to the incorporation of ESCC-PS and PD-L1. B. Kaplan–Meier survival curves of OS (6.3 vs 20.2 vs 34.8 months, P < 0.001) according to the incorporation of ESCC-PS and PD-L1. PFS progression-free survival, OS overall survival, ESCC-PS esophageal squamous cell cancer-pathomics signature

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us